Advertisement
Advertisement

HALO

HALO logo

Halozyme Therapeutics, Inc.

81.48
USD
Sponsored
+0.25
+0.31%
Feb 09, 11:56 UTC -5
Open

Halozyme Therapeutics, Inc. Financial Snapshot

Market Cap
9.58B
Beta
0.97
Earnings Per Share (EPS)
4.75
Price-to-Book (P/B) Ratio
18.30
Operating Margin
53.12%
Total Debt/Equity (D/E)
299.80%
P/E Ratio
14.74
Return on Equity (ROE)
156.95%
Current Ratio
1.59%
Free Cash Flow
875.86M

Earnings Chart

Trending Stocks

Advertisement